Yanchun Lily Li

Yanchun “Lily” Li is a cross-border investor, strategic advisor and philanthropist who connects worlds that rarely meet. In 2005 she led the first mainland Chinese pharmaceutical company to list on the New York Stock Exchange. She is Founder and CEO of Harvard Wealth Strategy & Management in New York, advising founders and entrepreneurial families on listings, cross-border growth and generational stewardship, with investments in AI, biotechnology and longevity. She helps exceptional founders build not only successful companies, but enduring global platforms. She is Founder and Chair of the Lily Li Future Foundation, Co-Chair of the Olive Council of Scholas Occurrentes, Vice Chair of the Global Solidarity Institute, a Trustee of the International Vaccine Institute, and a member of the Harvard Kennedy School Dean’s Council.

Her conviction: capital is never neutral. It carries the intentions of whoever allocates it — and her work is to see that those intentions serve human dignity.

Lily Li 是国际投资人、战略顾问与慈善家。2005年，她带领第一家中国大陆医药企业登陆纽约证券交易所。现任纽约 Harvard Wealth Strategy & Management 创始人兼首席执行官，为创业者与企业家族提供上市、跨境成长与财富代际传承的战略顾问服务，投资聚焦人工智能、生物科技与长寿科学。她是 Lily Li Future Foundation 创始人兼主席、教宗方济各创立的全球教育运动 Scholas Occurrentes 全球董事会（Olive Council）联合主席、全球团结研究院副主席、国际疫苗研究所理事、哈佛肯尼迪学院院长顾问委员会成员。

她的信念：资本从来不是中性的——它携带着配置者的意图；而她要做的，是让这份意图服务于人的尊严。